The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association’s 85th Scientific Sessions. At last year’s edition in Orlando, type 2 diabetes dominated the conversation. This time around, type 2 remained a hot topic, alongside new players in the continuous glucose monitor (CGM) and automated insulin delivery market, […]
Beta Bionics
Analysts expect Beta Bionics patch pump launch by 2027
BTIG analysts said today that Beta Bionics (Nasdaq:BBNX) expects to launch a new insulin patch pump system in the U.S. by the end of 2027. Marie Thibault, Sam Eiber and Alexandra Pang said the company revealed the new Mint system in a live demonstration at the American Diabetes Association’s 85th Scientific Sessions, outlining its plan […]
Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
Beta Bionics (Nasdaq:BBNX) announced today that it agreed to integrate its iLet bionic pancreas with a future dual sensor from Abbott (NYSE:ABT). The agreement pairs the iLet automated insulin delivery system with the sensor designed to continuously monitor glucose and ketone levels. This marks the third such integration for the Abbott dual sensor. The company […]
Beta Bionics posts Q1 sales beat, raises 2025 guidance
Beta Bionics (Nasdaq:BBNX) shares remained unmoved after hours today on first-quarter results that topped the consensus sales forecast. Following its first-quarter performance, Beta Bionics increased its full-year guidance. After previously projecting between $80 million and $85 million in revenue, it now expects between $82 million and $87 million. The Irvine, California-based automated insulin delivery technology developer […]
Doctors issue call to action to eliminate barriers to automated insulin delivery
Key opinion leaders issued a call to action to the diabetes community to recognize the importance of automated insulin delivery (AID). A number of doctors issued this call, published by Mary Ann Liebert’s Diabetes Technology & Therapeutics, to implement the advances made in the AID technology space. They say pivotal trials and real-world data support […]
Beta Bionics posts Q4 sales beat to cap off ‘momentum-building year’
Beta Bionics (Nasdaq:BBNX) shares rose after hours today on fourth-quarter results that topped the consensus sales forecast. Shares of BBNX ticked up nearly 2% to $15.50 apiece in poost-market trading today. This is the company’s first quarterly earnings report after it went public through a $234.6 million IPO in January. The Irvine, California-based automated insulin […]
Beta Bionics founder talks bringing ‘bionic pancreas’ to market
Around 25 years ago, Ed Damiano’s 11-month-old son developed type 1 diabetes. Damiano, a professor of mechanical engineering, made it his goal to make it easier to manage his young son’s condition. Speaking on a panel at the MassMedic 2025 MedTech Symposium in Boston earlier this month, Damiano said: “I started to think about ways […]
Beta Bionics goes public with upsized $234.6M IPO
Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly upsized initial public offering (IPO). Earlier this month, the company filed a registration statement with the SEC relating to a proposed IPO. Beta Bionics, maker of the iLet bionic pancreas, later filed a prospectus outlining its aim to bring in $114.4 million in […]
Beta Bionics to raise $114.4M in IPO
Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO). Earlier this month, the maker of the iLet bionic pancreas filed a registration statement with the SEC relating to a proposed IPO. Irvine, California-based Beta Bionics filed to list its common stock on the Nasdaq market […]
Beta Bionics is proposing an IPO
Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public offering (IPO). The amount of shares of common stock included in the IPO and the price range remain undetermined. Irvine, California-based Beta Bionics filed to list its common stock on the Nasdaq market under the “BBNX” […]
